15 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
of the previously identified or similar threats could cause a security incident or other interruption. If such an event were to occur and cause interruptions … and techniques change frequently, are often sophisticated in nature, and may not be
Table of Contents
detected until after a security incident has
424B7
OBSVF
ObsEva SA
3 Mar 22
Prospectus with selling stockholder info
4:43pm
of the common shares. We will bear all fees and expenses incident to our obligation to register the common shares.
The selling shareholders may sell all
F-3
OBSVF
ObsEva SA
17 Feb 22
Shelf registration (foreign)
4:14pm
of the proceeds from the sale by the selling shareholders of the common shares. We will bear all fees and expenses incident to our obligation
6-K
EX-99.3
xvh53ndf
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
wsdvynqd4u 3y
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
ote8z7vehe9
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.2
n2w8w8pe9et49aum
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
dqhlm
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
56n1w1mtc
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
2j7zi3 z256exg51m
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-1.1
gldrv
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
tto7e3
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
jbwg6oz4l 7f
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
- Prev
- 1
- Next